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ABSTRACT
Nucleic acid aptamers can potentially be developed
as broad-spectrum antiviral agents. Single-stranded
DNA (ssDNA) aptamer RT1t49 inhibits reverse
transcriptases (RT) from HIV-1 and diverse lentiviral
subtypes with low nanomolar values of Kd and IC50.
To dissect the structural requirements for inhibition,
RT-catalyzed DNA polymerization was measured in
the presence of RT1t49 variants. Three structural
domains were found to be essential for RT inhibition
by RT1t49: a 50 stem (stem I), a connector and a
30 stem (stem II) capable of forming multiple
secondary structures. Stem I tolerates considerable
sequence plasticity, suggesting that it is recognized
by RT more by structure than by sequence-specific
contacts. Truncating five nucleotides from the
30 end prevents formation of the most stable
stem II structure, yet has little effect on IC50
across diverse HIV-1, HIV-2 and SIVCPZ RT. When
bound to wild-type RT or an RNase H active site
mutant, site-specifically generated hydroxyl radicals
cleave after nucleotide A32. Cleavage is eliminated
by either of two polymerase (pol)-active site
mutants, strongly suggesting that A32 lies within
the RT pol-active site. These data suggest a model
of ssDNA aptamer–RT interactions and provide an
improved molecular understanding of a potent,
broad-spectrum ssDNA aptamer.
INTRODUCTION
HIV-1 reverse transcriptase (RT) copies the viral genomic
RNA into double-stranded DNA (dsDNA). Due to its
essential role in viral replication and to the early
availability of RT inhibitors, RT has been a leading
target for anti-retroviral treatments. Currently, over
half of the US Food and Drug Administration (FDA)
approved anti-retroviral drugs target RT. These drugs
fall into two categories: nucleoside analog RT inhibitors
(NRTI) block extension of the template DNA upon
incorporation into the replicating genome, and non-
nucleoside RT inhibitors (NNRTI) bind a hydrophopic
pocket near the RT active site resulting in allosteric
inhibition (1,2). Although these small-molecule inhibitors
have helped slow the progression of AIDS, their long-term
utility can be compromised by cellular toxicity and
the emergence of drug resistant HIV-1 strains (3–6).
The proven eﬀectiveness of anti-RT therapeutics validates
the push for new molecular inhibitors of RT. Antagonists
that utilize novel inhibition mechanisms are especially
attractive in that they may be less cytotoxic and may avoid
the current escape mutations associated with NRTIs
and NNRTIs.
High-aﬃnity DNA and RNA aptamers have been
selected to bind RT. These aptamers inhibit both the
polymerase (pol) and RNase H functions of the protein
in vitro (7–12) and have the potential to inhibit all steps of
reverse transcription, including RNA- and DNA-primed
extensions on either RNA- or DNA-templates, strand
displacement and RNA cleavage by RNase H (12).
Half-maximal inhibition is observed in the picomolar to
low micromolar range (7–14), with RNA-primed reactions
showing the greatest susceptibility to aptamer inhibition
(12). Aptamers appear to compete with primer/template
for binding to RT (8,9,15,16), and have accordingly
been referred to by some authors as template-primer
analog RT inhibitors (TRTIs) (16). Biochemical probing
(17) and crystallographic studies (18) have shown that a
canonical RNA aptamer folds into a pseudoknot structure
and binds to RT in the primer-template binding-cleft.
Because aptamers exploit inhibitory mechanisms that are
distinct from those utilized by small-molecule inhibitors,
they oﬀer a unique opportunity in combating HIV.
Several studies have shown that intracellular expression
of RNA aptamers to RT protects these cells from HIV-1
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virus produced in cells expressing RNA aptamers are
less infectious when applied to aptamer-naı¨ve cells (22).
This protection extended across multiple HIV-1 subtypes
and several drug-resistant viruses (22). Other studies have
identiﬁed ssDNA aptamers and double-stranded, sulfur-
containing thioaptamers that bind the RNase H domain
of RT (14). Although the aﬃnity of these aptamers for
RT is much weaker than that of ssDNA aptamer RT1t49
(described below), these aptamers also aﬀord protection
to cells when administered prior to challenge with low to
moderate levels of virus (7,14). The demonstrated antiviral
eﬃcacy of aptamers in three distinct modes—expression
within target cells, co-packaging into nascent virus within
producer cells and exogenous delivery to target cells—
motivate further analysis of the molecular basis of RT
inhibition by aptamers.
Aptamer RT1 is an 81-nucleotide ssDNA that was
selected from a degenerate library containing 35 random
positions. It has a reported Kd value of 1nM and IC50
(reported as Ki) value of 50.3nM, reﬂecting an
RT-binding aﬃnity that is more than 1000 times greater
than that of the library from which it originated (9).
The authors introduced random mutations into RT1 and
re-selected molecules that retained a high aﬃnity for
HIV-1 RT (2nM after six SELEX cycles versus  1500nM
Kd for the partially randomized library). Comparative
sequence analysis of the reselected species enabled
truncation of the original 81-nucleotide aptamer to a
49-nucleotide version, denoted RT1t49, with similar
aﬃnity for HIV-1 RT (Kd 4nM) (9). A recent study
using capillary electrophoresis has shown that RT1t49
binds to HIV-1 RT with a 1:1 stoichiometry, whereas two
other DNA aptamers from the same selection (RT12 and
RT26) appear to form complexes with two aptamers per
RT (24). Using in vitro enzymatic extension assays, we
have previously shown that the potent inhibition of RT
polymerization and RNase H activities by RT1t49 extends
across multiple subtypes of HIV-1, HIV-2 and SIVCPZ
RTs, whereas another ssDNA aptamer (RT8) inhibited
only the HIV-1 RT subtype utilized in the original
selection (36). Fisher et al. (25) have demonstrated
inhibition of multiple drug-resistant forms of HIV-1 RT
by RT1t49, and observed that mutations in RT that give
rise to biochemical resistance to RT1t49 come at a price
of a severe replication deﬁciency in the virus (16). Each of
these observations highlights the importance of deﬁning
the molecular contacts that determine aptamer speciﬁcity.
There is little information on the speciﬁc nucleic acid
structural requirements of RT1t49 for RT binding.
Therefore, we analyzed a panel of RT1t49 variants to
dissect the secondary structural requirements of RT1t49.
We found that a stable, stem–loop structure with
considerable sequence plasticity is important at the
50-end, as is a shorter stem near the 30-end, and that
multiple regions of the molecule tolerate alterations from
the primary sequence. The results of our mutational and
deletion analysis of RT1t49 support a model wherein
several alternative secondary structures contribute to
the high-potency inhibition of HIV-1 RT by RT1t49.
In addition, both solution and site-speciﬁcally generated
hydroxyl radical probing enabled us to identify a speciﬁc
interaction between RT1t49 position A32 and the
pol-active site of HIV-1 RT. Finally, we show that a
truncated version of RT1t49 that is unable to form the
previously proposed stem II structure nevertheless
retains an ability to inhibit RTs across multiple subtypes
of HIV-1, HIV-2 and SIVCPZ. The implications of these
results for drug resistance and for potential drug develop-
ment are discussed.
MATERIALS AND METHODS
Materials
Cy3 ﬂuorophore-labeled and unlabeled DNA oligonucleo-
tides were synthesized by Integrated DNA Technologies
(Coralville, IA, USA). Nuclease S1 was purchased from
Roche and used as recommended by the manufacturer at
a dilution of 1:2000 in S1 nuclease buﬀer. Radioactive
nucleotides were obtained from Amersham Biosciences
(Piscataway, NJ, USA). RT from HIV-1 strain HXB2
(used in most experiments) and from other sources
(used in Table 1) were expressed in Escherichia coli and
puriﬁed as described (37).
DNA-dependent DNA polymerization assays
For RT1t49 mutational analysis, DNA-dependent DNA
polymerization was monitored by single nucleotide
(ddCTP) extension of a Cy3-labeled 18nt primer
(50 Cy3-GTCCCTGTTCGGGCGCCA 30) on a 40-nt
template (50 CAGTGTGGAAAATCTCTAGCAGTGG
CGCCCGAACAGGGAC-30). A 1:1.5 ratio of primer to
template (25nM primer, 37.5nM template) resulted
in nearly complete annealing of primer with template
(data not shown). Therefore, reactions were performed
using 25nM primer, 37.5nM template and 100ng/ml
bovine serum albumin (BSA) in 1x reaction buﬀer
(75mM KCl, 5mM MgCl2, 50mM Tris–HCl pH 8.3,
10mM DTT) and 0.2mM ddCTP. Primer and template
strands were heated together at 958C for 2min and
allowed to anneal at room temperature for 5min.
Synthetic ssDNA aptamers were re-suspended in water
and added to the primer/template mix (ﬁnal concentra-
tions from 0.3 to 729nM, in 3-fold serial dilution
increments) prior to the addition of RT. Extension
reactions were initiated by addition of HIV-1 RT
(0.4nM ﬁnal active concentration) and incubated at
378C. Reactions were quenched after 3min with two
volumes of stop buﬀer (urea-saturated 95% formamide,
50mM EDTA and bromophenol blue). Reaction products
were separated on 15% denaturing (7.5M urea) poly-
acrylamide gels and scanned for Cy3 ﬂuorescence using
a Molecular Dynamics Typhoon Phosphorimager. Image
analysis was performed using ImageQuant 5.2 software.
The percent extension was calculated by dividing the
ﬂuorescent signal from the N+1 extended product by the
sum of the signals from the unextended and extended
primer bands. These data were normalized for extension
without aptamer (100% relative extension) and without
RT (0% relative extension). Normalized data were ﬁt to
5040 Nucleic Acids Research, 2007, Vol. 35, No. 15a sigmoidal dose-response curve with a constant slope
of 1 with GraphPad Prism software using Equation (1):
Y ¼ 100=ð1 þ 10ðLog IC50 xÞÞ 1
Where X is the log of inhibitor concentration and Y is
measured relative percent extended at a given inhibitor
concentration.
Aptamer inhibition of primer extension by RTs from
across HIV-1, HIV-2 and SIVCPZ clades was performed
as previously described (36). Brieﬂy, the Cy3-labeled 18nt
primer was extended on a 103-nt DNA template
corresponding to the HXB2 50 LTR U5 and PBS
sequences (50-AAGTAGTGTGTGCCCGTCTGTTGTG
TGACTCTGGTAACTAGAGATCCCTCAGACCCTT
TTAGTCAGTGTGGAAAATCTCTAGCAGTGGCGC
CCGAACAGGGAC-30). The PBS sequence is under-
lined. Reactions were assembled in the 1x RT reaction
buﬀer with 30nM primer, 45nM DNA template and
0.2mM dNTPs. Aptamers were added to ﬁnal concentra-
tions of 0.3 to 243 nM, in 3-fold serial dilution increments.
To maximize the dynamic range of polymerization
reactions, extension proceeded until just prior to reaching
the plateau phase of the product formation curve in
unchallenged assays (10min, data not shown). Reactions
were initiated by the addition of enzyme to 0.4nM ﬁnal
active site concentration, quenched after 10min in 378C
with two volumes of 95% formamide, 50mM EDTA
and then analyzed as above. Three independent datasets
were averaged to calculate the reported IC50 values;
uncertainties reﬂect the standard deviations among IC50
values.
S1nuclease digestion of RT1t49
For S1 nuclease digestion, [
32P] 50-end-labeled DNA
aptamer (410
6c.p.m.) was unfolded at 958C for 2min
with 1xS1 nuclease buﬀer (Roche) in the presence of
BSA (100ng/ml), allowed to fold at room temperature for
5min, and then kept on ice. Reactions were initiated
by adding an equal volume of S1 nuclease (0.4U/mLi n
1xS1 nuclease buﬀer.) After 15min on ice, reactions were
quenched with two volumes of stop buﬀer (urea-saturated
95% formamide, 50mM EDTA and bromophenol blue)
and electrophoresed on a 12% denaturing (7.5M urea)
polyacrylamide sequencing gel. The gel was dried, exposed
to a storage phosphor screen and analyzed with the
Molecular Dynamics Typhoon Phosphorimager.
Structure probing by site-specifically generated
andbulk hydroxyl radicals
Previously, Gotte et al. (26) showed that by replacing
the Mg(II) in the RNase H active site with Fe(II) allows
the site-speciﬁc generation of OH  radicals that cleave the
closest nucleotide in the DNA. Using the same methodol-
ogy, we monitored both Fe(II)-dependent hydroxyl
radical cleavage due to pol- and RNase H-speciﬁc
cleavage as well as hydroxyl radical cleavage from bulk
solution. Site-speciﬁcally generated hydroxyl radicals were
generated as described (26,27). Brieﬂy, 2.5mlo f[
32P] 50-
end-labeled DNA aptamer (410
6c.p.m.) was incubated
in 10nM sodium cacodylate, 0.1mM EDTA, 50mM KCl,
1mM CaCl2, 5mM MgCl2 and 100mg/ml BSA in a total
volume of 16ml. The sample was heated to 958C for 2min
and cooled to room temperature for 10min to facilitate
aptamer folding. To a ﬁnal concentration of 560 nM, 2ml
HIV-1 RT (or buﬀer) was added to the bottom of a 1.5ml
eppendorf tube. The hydroxyl radical solution was made
by adding 1ml of a freshly prepared Fe(II)-EDTA solution
to the wall of the tube. A 1ml drop containing 0.6%
hydrogen peroxide (freshly diluted from a 30% stock) was
added directly to the Fe(II)-EDTA solution, and ﬁnally
1ml of 20mM sodium ascorbate was added to the Fe(II)-
EDTA/H2O2 solution. The reaction was initiated by
‘ﬂicking’ the hydroxyl radical solution into the DNA
aptamer solution in the bottom and was quenched with
stop solution (2.5mM thiourea, 0.1M sodium acetate and
20mg glycogen as carrier) 2min later. Reaction products
were precipitated with three volumes of 100% ethanol,
and the DNA pellet was re-suspended in 20ml of loading
buﬀer containing 95% formamide, 50mM EDTA, bro-
mophenol blue and xylene cyanole and electrophoresed on
a 12% denaturing (7.5M Urea) polyacrylamide sequen-
cing gel and analyzed as above.
RESULTS AND DISCUSSION
Inhibition of HIV-1 polactivity by RT1t49 as measured
by singlenucleotide incorporation
Single-stranded DNA aptamer RT1t49 has previously
been shown to be an eﬀective inhibitor of HIV-1 reverse
transcriptase (9). In the present study, we set out to
determine the sequence and structural constraints asso-
ciated with this inhibition. We have previously shown that
RNA-dependent DNA polymerization is more susceptible
to aptamer inhibition when compared with DNA-depen-
dent DNA polymerization, therefore we have chosen to
evaluate the inhibition of our aptamer constructs using
DNA-dependent DNA polymerization assays (12). Single
nucleotide incorporation assays oﬀer a convenient and
readily quantiﬁable means of assessing DNA polymeriza-
tion activity (12). For these experiments we used a Cy3-
labeled 18-nucleotide DNA primer corresponding to the
Table 1. RT1t49( 5) inhibition across HIV-1, HIV-2 and SIVCPZ RTs
Subtype Viral isolate IC50 (nM, Mean SD)
RT1t49 RT1t49(-5)
DDDP DDDP
B HXB2 9.1 4.2 7.6 3.7
A/D 92UG021 9.7 2.3 9.7 2.2
C 98CN008 4.0 2.2 1.6 0.6
A/E 93TH253.3 18.4 7.5 25.3 6.6
A 94CY017.41 12.0 5.3 8.6 2.9
G RU570 16.9 7.9 7.6 2.8
CPZ-US 12.3 5.0 8.7 1.3
MVP5180 9.7 3.9 7.9 2.3
CPZ-TAN1 9.7 4.4 5.5 1.6
EHO-287 90 36 110 14
IC50 values derived from full extension of an 18nt primer on
a103nt template.
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Lys,3 annealed to a 40-nucleotide
DNA template containing the HIV-1 primer binding site
(PBS) (Figure 1A). Annealed primer/template was present
in excess of primer/template over RT to allow multiple-
turnover conditions. Increasing amounts of inhibitor were
added to the reaction mixture prior to the addition of RT.
Fitting the data for the RT1t49 titration to a sigmoidal
dose-response curve gives half-maximal inhibition (IC50)
at 3.6 0.9nM (Figure 1B and C). This equation assumes
both a 1:1 aptamer:RT stoichiometry and that the
aptamer is in excess of RT near the IC50 value. Because
the total RT concentration is comparable with this value
of IC50, these data were also ﬁt to the quadratic form of
the binding equation and to a sigmoidal dose-response
curve with a variable slope function. For each ﬁt, the
reported IC50 value fell within the error of the original ﬁt
(data not shown). Therefore, 3.6nM was used throughout
the rest of this study as the reference IC50 against which all
others were compared.
Evidence supporting thepossibility of multiple
RT1t49conformations
The MFOLD algorithm (28) on the Integrated DNA
Technologies web server (www.idtdna.com) identiﬁed
three potential secondary structures for RT1t49
(Figure 2). The most stable structure (G= 4.7) is
also the one proposed by Schneider et al. (9) (Figure 2A,
hereon referred to as ‘structure A’). All three conforma-
tions share an identical stem I at the 50 end, followed by
a single-stranded connector and a variable stem II at the
30 end. The nucleotides responsible for the alternative
stem II structures are highlighted in Figure 2 according to
base-pairing potential. Overall, the structure of stem II
contributes signiﬁcantly to the stability of RT1t49 as
structure B (Figure 2B) and structure C (Figure 2C) are
less stable (G= 3.6 and  2.7, respectively) than
structure A. To determine whether structural variability
inﬂuences RT inhibition potency, a series of RT1t49
sequence and deletion mutants were created. Their eﬀects
on RT inhibition are described subsequently.
MultipleconformationsofstemIIcontributetoRTinhibition
Three separate mutations were introduced into stem II of
RT1t49 (Figure 3). The ﬁrst of these was designed to
address the importance of the three-nucleotide loop
capping the end of stem II in structure A (Figure 3A).
Converting the predicted tri-loop to an unrelated stable
tetra-loop (AAC!TGCG) increased IC50 nearly 20-fold
to 65 10nM. To determine whether this perturbation
was due to loss of speciﬁc contacts between RT and the
tri-loop at the end of stem 2, or to a decrease in the ability
of RT1t49 to assume alternative stem II structures, the
terminal pair of stem II was changed from G–T to a G–C
Watson–Crick base pair. This mutation stabilized the
proposed stem by  0.6kcal/mol and had little conse-
quence on the IC50 (5.5 1.4nM). While T45 is not
predicted to be base-paired in the alternate stem II
RT1t49: Dose-Response
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Figure 1. RT1t49 inhibition of single nucleotide incorporation by
HIV-1 RT. (A) Schematic of the single nucleotide incorporation assay.
Extension was performed using a Cy3-labeled 18nt DNA primer
annealed with an unlabeled 40nt template. (B) Representative gel of
a standard assay with ﬁnal aptamer concentrations ranging from 0.3 to
243nM and a no aptamer control. (C) The plot of normalized percent
extension as a function of aptamer concentration from three
independent experiments was used to determine the IC50 value.
Normalized data were ﬁt to a sigmoidal dose–response curve using a
constant slope. The calculated IC50 of 3.6 0.9nM was used
throughout the rest of this study as the reference against which all
others were compared.
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(A) Previously proposed secondary structure by Schneider et al. (9).
The three structure regions (50 stem I, connector region, and 30 stem II)
are marked. Nucleotides shown in red and blue are base-paired in
structure B (Blue) or C (Red).
5042 Nucleic Acids Research, 2007, Vol. 35, No. 15structures, the increased stability in structure A suggests a
more-stable stem II is well tolerated. The third alteration
disrupted the stem II in structure A by simultaneously
introducing mutations G47A and G48A. Surprisingly,
this mutation had no eﬀect on the observed IC50
(3.1 0.5nM).
The results described above suggest that either the stem
II associated with structure A is not an important
structural element for RT inhibition or that alternative
structures play a role in the high-aﬃnity inhibition by
RT1t49 and can be accommodated by these mutations.
To diﬀerentiate between these possibilities, a series of
RT1t49 variants were created, each with successive
single nucleotide deletions from the 30 end until the
entire stem II of structure A was completely deleted. Up
to ﬁve nucleotides ( 1 through  5) could be deleted
(creating a 44-nt species terminating with C44) without
signiﬁcantly aﬀecting the IC50 values (Figure 3C), which
ranged from 5.1 to 8.1nM. Clearly RT1t49 variants are
still capable of a high level of inhibition even when the
stem II of structure A is unable to form. However,
removal of one additional nucleotide ( 6) caused a
dramatic jump in IC50 to 138 68nM. Further deletions
of nucleotides  7 through  10 all resulted in IC50 values
between 215 and 285nM, while additional deletions
( 11 through  13) eliminated nearly all inhibition and
yielded IC50 values near 1mM. These results strongly
suggest that structures B or C (or both) contribute
signiﬁcantly to the inhibition of HIV-1 RT.
The connector region andits role inRT inhibition
Several mutations and deletions were made to address the
importance of the length, sequence and single-stranded
character of the short connector region separating the two
stems of RT1t49 (Figure 4). Shortening this connector
from six nucleotides to ﬁve by deleting A31 had only
a minor eﬀect, increasing IC50 to 8.3 2.1nM. However,
deletion of both A31 and A32 raised the overall IC50 value
nearly 40-fold to 127 29nM, and deletion of A31,
A32 and A33 produced a 100-fold increase in IC50
(361 81nM) relative to that of RT1t49. Deletion of
nucleotides C34 and T35 separately increased IC50 to
38 18nM and 58 6nM, respectively, but the simulta-
neous deletion of both nearly eliminated inhibitory
function at all aptamer concentrations surveyed, yielding
a calculated IC50 that approached 1mM. Several base-
substitution mutations were introduced to test the
importance of individual nucleotides within the connec-
tion region. Mutation C34A increased the IC50 to
100 35nM, mutation T35A increased the IC50 to
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Figure 3. Mutations to stem II of RT1t49. Individual and combination mutations were created within stem II of structure A. (A) The mutation
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Nucleic Acids Research, 2007, Vol. 35, No. 15 5043228 96nM and the combination mutation of C34A/
T35A increased the IC50 to4500nM. These observations
clearly indicate that the single-stranded connector between
stems I and II plays an important role in RT inhibition
by RT1t49. Several individual nucleotides are implicated
as either making individual, speciﬁc contacts with the
protein or in forming the alternative stem II structures
found in structures B and C.
Nucleotides A31–A33 are not predicted by MFOLD to
be paired in any of the structures. These nucleotides may
serve to establish the overall spacing of the two stems
of the aptamer. Subsets of the nucleotides C34–T37 are
base-paired in structures B and C. Mutations to both C34
and T35 have detrimental eﬀects on the ability of RT1t49
to inhibit RT, consistent with at least two models for RT
inhibition: one in which RT contacts these two nucleo-
tides, and one in which they are involved in the alternative
stem II conformation shown in structure B.
Structural andsequence requirements forstem I
Three sets of mutations were introduced into RT1t49
to determine the consequences of weakening, strengthen-
ing or altering the sequence of stem I (Figure 5).
The C4A and T11A/T12A mutations weakened the
base-pairing potential of stem I, and caused a nearly
5-fold increase in the IC50 value relative to that of RT1t49
(IC50=17 1.2nM and 21 3.3nM, respectively.)
Disruption of T8–A23 and G9–C22bp near the center
of stem 1 prevented formation of stem I altogether
(as predicted using MFOLD) and yielded a more
substantial loss of inhibition (IC50=70 29nM).
Mutations that increased stem I stability had only
modest eﬀects on RT inhibition. Three of the four mutants
surveyed gave IC50 values within 2-fold of the parental
RT1t49. Especially interesting is the absence of signiﬁcant
eﬀect on IC50 for the two constructs that fully pair the
internal bulges. Crystallographic analysis has shown that
the primer-template binding cleft between the pol and
RNase H active sites of RT can accommodate between
17 and 18bp of dsDNA (29–32), which takes on an
A-form/B-form mixed helix and has a bend of 408 to 458
at the junction between the A-form and B-form segments
(31). It has been suggested that aptamers with pre-existing
bends may be recognized more easily than a simple
uninterrupted helix by RT (8,9). In particular, the
unpaired nucleotides in stem I of RT1t49 have been
proposed to serve this role (9). However, the results above
suggest that the helical nature of stem I is more important
for RT recognition than bending associated with the
bulged positions within the stem.
To exclude the possibility of aptamer recognition
through sequence-speciﬁc interactions, several mutations
were introduced wherein nucleotides in one strand were
switched with those in the other strand in various parts of
stem 1 (Figure 5B and C). Inverting the base-paired region
in the beginning segment of stem I (RT1t49-Inv A)
resulted in a moderate increase in IC50 (16 4.9nM).
When the middle segment of stem I was inverted
(RT1t49-Inv B) there was only a small increase in IC50
(10 3.2nM). The two alterations were not additive,
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5044 Nucleic Acids Research, 2007, Vol. 35, No. 15as introduction of the two inversions simultaneously
(RT1t49-Inv A+B) resulted in an IC50 of 9.3 2.6nM.
Furthermore, changing most of the nucleotides in both
stems to other Watson–Crick pairs (variant RT1t49-
Change Sequences) yielded an IC50 value (8.8 3.1nM)
that is in line with the other variants in this series. Thus,
RT recognizes stem I of RT1t49 in a fashion that is
predominantly independent of sequence.
Secondary structural determination byenzymatic probing
To deﬁne more precisely the secondary structure of the
folded aptamer, two versions of RT1t49 were subjected to
enzymatic digestion with S1 nuclease (Figure 6). For the
full-length RT1t49, major cleavages are observed at
nucleotides G5/G6 and from A31-G36, with secondary
cleavages occurring at nucleotides C3, T12–T21, A40–G41
and A43–T45. These weaker cleavages could indicate that
the dominant solution structure is in equilibrium with one
or more minor, alternative folds. When higher molecular
weight fractions of these same samples were separated by
running the samples longer, no S1 cleavage was observed
at nucleotides T46 through A49 of RT1t49, indicating
that these nucleotides are base-paired or otherwise
structured in the dominant conformation (data not
shown). Thus, the S1 nuclease digestion of RT1t49
supports the structural prediction of structure A. For
aptamer RT1t49(-5), which lacks the 30-most 5 nucleo-
tides, the cleavage patterns are essentially identical at
G5/G6 and from A31–A36, although the secondary
cleavages sites at nucleotides A17–T21 appear to be
cleaved less eﬃciently than in RT1t49. Although both
aptamers appear to form identical stem I and possess
similar connection regions, the RT1t49(-5) deletion
mutant lacks the capability of folding into a structure
with the proposed stem II in structure A. Interestingly,
the secondary cleavages observed beyond nucleotide
T36 in RT1t49 are absent from the digestion pattern
for RT1t49(-5). These data suggest that the 30-terminal
segment of RT1t49(-5) is base-paired or structured (as in
structure B and C), and they support our hypothesis
that alternative structures within stem II contribute to
inhibition of HIV-1 RT.
RT1t49(-5) inhibits RT from HIV-1,HIV-2 andSIVCPZRT
We have recently shown that RT1t49 inhibits pol and
RNase H activities of RTs from diverse clades of HIV-1,
HIV-2 and SIVCPZ (36). The present work demonstrates
that multiple structures may contribute to inhibition of
HXB2 RT, raising the possibility that multi-clade inhibi-
tion may have been dependent upon access to multiple
structures. For example, some RTs may have been
inhibited only by the dominant solution structure (struc-
ture A) while others were inhibited only by one of the
alternatives (structure B or C). We therefore evaluated
the eﬀect of RT1t49( 5) on cross-clade inhibition of
DNA-dependent DNA pol extension of an 18-nt primer
on a 103-nt template. Inhibition by the full-length aptamer
(RT1t49) is essentially identical to inhibition by
RT1t49( 5) (Table I). The diﬀerence of the IC50 values
between pairs was not signiﬁcant, and we found that
RT’s from HIV-1 subtypes C and G were more than
2-fold more sensitive to inhibition by RT1t49( 5) than by
RT1t49. These data support our hypothesis that the stem
II associated with structure A is not essential for the
overall inhibition of HIV-1 RT and that the alternative
structures associated with stem II must contribute
signiﬁcantly to the inhibition of lentiviral RT.
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Figure 6. Enzymatic probing and solution structure of aptamer
RT1t49. Autoradiogram of a 12% polyacrylamide (7.5M Urea) gel
showing products of digestion with S1 nuclease, which cleaves ssDNA.
Products of 50 end-labeled RT1t49(-5) (lanes 1 and 2) or RT1t49
(lanes 4 and 5). Lane 3 was left intentionally blank. DNA aptamers
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in lanes 1 and 4. Single-stranded DNA regions that are accessible to S1
nuclease digestion are marked by vertical lines corresponding to their
position within RT1t49.
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point ofcontact
Previously Go ¨ tte et al.(26) showed the RNase H domain
of HIV-1 RT could utilize two distinct mechanisms to
cleave both the RNA template of DNA/RNA hybrids and
dsDNA (26). Replacing the Mg(II) in the RNase H active
site with Fe(II) allows the site-speciﬁc generation of OH 
radicals that cleave the closest nucleotide in the dsDNA.
Building on this concept, we evaluated whether RT1t49
and RT1t49(-5) bound with HIV-1 RT could react with
OH  radicals generated from Fe(II) bound at the active
sites of HIV-1 RT (Figure 7A). Both aptamers show
uniform, low-level reactivity to OH  radicals in the
absence of protein (lanes 2 and 7). Upon the addition
of wild-type RT, new major cleavages are observed at
nucleotides 11 and 32 (lanes 3 and 8). To determine
whether these sites of hyperactivity were due to Fe(II)
bound in the pol or RNase H active sites, wild-type RT
was replaced with mutants that selectively disrupt metal
ion binding in either the pol (D185N or D186N) or the
RNase H (E478Q) active sites. Although RNase H
catalytic activity can be rescued in the last mutant in the
presence of Mn(II) (33), this replacement abolishes RNase
H-directed, Fe(II)-mediated radical cleavage of dsDNA
(26). Cleavage at position 11 remained strong for all three
mutants, supporting aptamer being bound to the RT
mutants. No change in the cleavage pattern of either
aptamer was observed for the RNase H mutant (data not
shown), ruling out radical cleavage mediated by the
RNase H active site. In contrast, cleavage associated
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Figure 7. Site-speciﬁcally generated hydroxyl radical hyperactivity at the RT pol active site. (A) The cleavage patterns of uncomplexed aptamers
RT1t49(-5) and RT1t49 exposed to OH  radicals (lanes 2 and 7, respectively), or these same aptamers when bound with RT from HXB2 (lanes 3
and 8), with pol active-site mutant D185N (lanes 4 and 9) or with pol active-site mutant D186N (lanes 5 and 10). Lanes 1 and 6 show non-reacted
aptamers. (B) Representative graph plotting the intensity of bands from RT1t49( 5) from nucleotides 30 to 35 for HXB2 (continuous line),
D185N (dotted line) or D186N (dashed line). (C) The site of hypercleavage is mapped to the RT1t49 structure C.
5046 Nucleic Acids Research, 2007, Vol. 35, No. 15with nucleotide A32 was essentially eliminated in both
of the pol-active site mutants for both aptamers. A plot
of the intensity of cleavage from nucleotides 30–34 shows
a dramatic increase in cleavage of wild-type versus
pol-active site mutants at A32 (Figure 7B). These results
strongly suggest that A32 is located very near the
pol-active site.
Hydroxyl radical footprinting is an established method
for determining dsDNA binding domains and has been
used to evaluate helicity of dsDNA (27). Plotting the
intensity of bands from nucleotides 6 through 36 in these
OH  radical probing experiments provide further insight
into the structure of bound aptamer (Figure 8A and B).
Cleavage levels are above background for two regions
(nucleotides 10–15 and 22–27) when exposed to OH 
radicals in the presence of protein. These nucleotides are
located within stem I and are arranged such that these
regions pair with (or are opposite of) regions found within
the background intensity (Figure 8C). Overlaying these
sites with a crystal structure of HIV-1 RT bound to
a dsDNA primer-template [2HMI and 1RTD, (30,34)]
show this diﬀerence in intensities can be explained by the
formation of a double helix and that these regions would
be solvent exposed if they bound RT as primer-template
mimics (Figure 9A). Interestingly, this assignment places
A32 within the dNTP binding cleft and in direct contact
with the Mg(II) binding sites (Figure 9B), supporting our
results of hyperactive OH  radical cleavage associated
at the pol-active site. The lack of hyperactive OH  radical
cleavage at the RNase H active site can be readily
explained by this model, as stem I is too short to reach
the RNase H active site when A32 is in the pol active site.
Our data ascribe no speciﬁc structural role for the
30 stem II, although a reasonable extrapolation is that it
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Figure 8. Hydroxyl radical footprint of RT1t49 bound to HXB2 RT maps to a double helix structure. The pattern of cleavage from a representative
OH  radical experiment (A) was plotted from nucleotides 3 through 35 (B). (C) Peaks were mapped to structure C based on intensity compared with
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Nucleic Acids Research, 2007, Vol. 35, No. 15 5047extends beyond the active site to the ‘back side’ of RT,
interacting either with the ﬁngers (in analogy with the
50 unpaired template) or thumb domain.
Further modeling suggests RT1t49-resistant mutations
N255D and N265D (15,16) would be in direct contact
with nucleotides 27 and 5, respectively, and place these
amino acids in a position to inﬂuence interactions
with RT1t49. Mutation R277K has been shown to be
resistant to Type I RNA pseudoknot aptamers but not
to RT1t49 [(37), data not shown]. Based on our modeling,
this mutation faces away from the helix and may have
only minimal eﬀect RT1t49 binding (data not shown).
We believe understanding the molecular interactions
between RT and RT1t49 may lead to new insights into
the development of alternative therapeutics that can
inhibit broadly across the primate lentiviral family.
CONCLUSION
While a substantial body of work has been directed
towards understanding the essential structural features of
RNA aptamers (8,10,17) and their interactions with RT,
including a low-resolution crystal structure (18), there has
been much less work devoted to the overall structural
requirements and interactions of ssDNA aptamers with
RT. In light of the broad, cross-clade RT inhibition that
has only been observed for ssDNA aptamers, it is essential
to deﬁne the structural elements that contribute to this
broad inhibition. The present work details the inhibitory
potency of 42 variants of ssDNA aptamer RT1t49
designed to test speciﬁc structural features of the aptamer.
The results from this study support the hypothesis that
HIV-1 RT recognizes the long, base-paired structure of
stem I without substantial nucleotide speciﬁcity, a second
base-paired region (stem II) at the 30 end of the aptamer
and a single-stranded connector region that links stems I
and II. Additional stem II structures that form at the
30-most nucleotides of the connection domain may be
responsible for most or all of the observed inhibition.
Hydroxyl radical footprinting and site-speciﬁcally-
generated hyperactive OH  radical cleavage support our
model of RT1t49 binding to the primer-template binding
cleft as a TRTI and shed light on molecular contacts
between aptamer and RT, including speciﬁc interactions
between nucleotide position 32 and the RT pol-active site.
These results advance our understanding of how HIV-1
RT recognizes RT1t49 and lay a solid foundation for
establishing the requirements for cross-clade inhibitory
ssDNA aptamers.
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